ArticleCancer medicine2014

Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer.

Channing J Paller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.